Meeting of the Advisory Committee to the Director, Centers for Disease Control and Prevention, 3663-3664 [2024-01014]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 13 / Friday, January 19, 2024 / Notices
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
ATSDR will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. Do not submit comments by
email. ATSDR does not accept
comments by email.
Donata Green,
Associate Director, Office of Policy, Planning
and Partnerships, Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2024–01007 Filed 1–18–24; 8:45 am]
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2024–0003]
Meeting of the Advisory Committee to
the Director, Centers for Disease
Control and Prevention
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting for the Advisory
Committee to the Director, Centers for
Disease Control and Prevention (ACD,
CDC). This is a hybrid meeting,
accessible both in person and virtually
(webcast live via the World Wide Web).
It is open to the public and limited only
by the space available. Time will be
available for public comment.
DATES: The meeting will be held on
February 21, 2024, from 9 a.m. to 3 p.m.,
EST (times subject to change).
Written comments must be received
on or before February 5, 2024.
ADDRESSES: Meeting address: CDC
Roybal Campus, Building 21, Room
1204 A/B, 1600 Clifton Road NE,
Atlanta, Georgia 30329–4027.
Please note that the meeting location,
the CDC Roybal Campus, is a federal
facility and in-person access is limited
to United States citizens unless prior
authorizations, taking up to 30 to 60
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:42 Jan 18, 2024
Jkt 262001
days, have been made. Visitors must
follow all directions for access to CDC
facilities. Directions for visitors to CDC,
including safety requirements related to
COVID–19; are available at https://
www.cdc.gov/screening/visitors.html.
Registration: You must register to
attend this meeting in person. If you
wish to attend in person, please submit
a request by email to ACDirector@
cdc.gov at least 5 business days in
advance of the meeting. No registration
is required to view the meeting via the
World Wide Web. Information for
accessing the webcast will be available
at https://www.cdc.gov/about/advisorycommittee-director/.
Written comments: You may submit
comments, identified by Docket No.
CDC–2024–0003, by either of the
following methods below. Do not
submit comments for the docket by
email. CDC does not accept comments
for the docket by email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Kerry Caudwell, DPA, Centers
for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop H21–10,
Atlanta, Georgia 30329–4027. Attn:
Docket number CDC–2024–0003.
Instructions: All submissions received
must include the Agency name and
Docket Number. All relevant comments
received will be posted without change
to https://www.regulations.gov,
including any personal information
provided. For access to the docket to
read background documents or
comments received, go to https://
www.regulations.gov. Written comments
received in advance of the meeting will
be included in the official record of the
meeting.
FOR FURTHER INFORMATION CONTACT:
Kerry Caudwell, D.P.A., Office of the
Chief of Staff, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop H21–10, Atlanta,
Georgia 30329–4027, Telephone: (404)
639–0390; Email Address: ACDirector@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee to
the Director, CDC, shall (1) make
recommendations to the Director
regarding ways to prioritize the
activities of the agency in alignment
with the CDC Strategic Plan required
under section 305(c); H.R. 2617–1252;
(2) advise on ways to achieve or
improve performance metrics in relation
to the CDC Strategic Plan, and other
relevant metrics, as appropriate; (3)
provide advice and recommendations
on the development of the Strategic
Plan, and any subsequent updates, as
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
3663
appropriate; (4) advise on grant,
cooperative agreements, contracts, or
other transactions, as applicable; (5)
provide other advice to the Director, as
requested, to fulfill duties under
sections 301 and 311; and (6) appoint
subcommittees. The committee
recommends ways to prioritize CDC’s
activities, improve results, and address
health disparities. It also provides
guidance to help CDC work more
effectively with its various private and
public sector constituents to make
health protection a practical reality.
Matters to be Considered: The agenda
includes updates on CDC programs,
Director’s focus areas, and the Moving
Forward Initiative. Agenda items are
subject to change as priorities dictate.
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Please note that comments
received, including attachments and
other supporting materials, are part of
the public record and are subject to
public disclosure. Comments will be
posted on https://www.regulations.gov.
Therefore, do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Written Public Comment: The docket
will be opened to receive written
comments on January 19, 2024 through
February 5, 2024.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\19JAN1.SGM
19JAN1
3664
Federal Register / Vol. 89, No. 13 / Friday, January 19, 2024 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–01014 Filed 1–18–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for Office of Management
and Budget Review; Runaway and
Homeless Youth Prevention
Demonstration Prevention Plans (New
Collection)
Family and Youth Services
Bureau, Administration for Children
and Families, U.S. Department of Health
and Human Services.
ACTION: Request for public comments.
AGENCY:
The Family and Youth
Service Bureau (FYSB) is proposing to
collect comprehensive Prevention Plans
from grant recipients that have been
awarded funding for a new prevention
demonstration project to design and
implement prevention and intervention
services tailored to prevent at-risk youth
from experiencing homelessness.
DATES: Comments due within 30 days of
publication. OMB must decide about the
collection of information between 30
and 60 days after publication of this
SUMMARY:
of homelessness and their families. The
RHY–PDP has two phases with the first
phase serving as a 6-month timeline for
grant recipients to develop and submit
a comprehensive prevention plan to
prevent youth homelessness.
The Prevention Plans can include:
• Grantee definition of prevention
• Summary of risk and protective
factors for youth experiencing
homelessness
• How grantees will identify at risk
youth to include existing data to assist
in identification
• Referral strategies for youth
• Explanation of the process of how
youth with lived experience and
community partners co-designed the
prevention plan
• List of prevention interventions
• All related goals and performances
measures planned
• List of community partners and
their roles.
FYSB will utilize the Prevention
Plans to provide technical assistance to
grantees, as needed, and will post the
Prevention Plans to the FYSB website
for grantees’ peer-to-peer learning.
Respondents: All grant recipients that
receive an RHY–PDP grant for the
prevention demonstration.
Total Burden Estimates
FYSB awarded 11 grants in September
2023 and anticipates awarding a second
cohort next year. The number of
respondents reflects a potential second
cohort of grant recipients that would
also be required to submit the
Prevention Plan.
Instrument
Total number of
respondents
Total number of
responses per
respondent
Average burden
hours per
response
Total burden
hours
FYSB RHY–PDP Prevention Plan ...........................................
26
1
60
1,560
Authority: Section 343 of the
Runaway and Homeless Youth Act
authorizes the award of grants for
research, evaluation, demonstration,
and service projects (34 U.S.C. 11243).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Mary B. Jones,
ACF/OPRE Certifying Officer.
Submission for Office of Management
and Budget Review; Application
Requirements for the Low Income
Home Energy Assistance Program
(LIHEAP) Model Plan Application
(Office of Management and Budget
#0970–0075)
[FR Doc. 2024–00964 Filed 1–18–24; 8:45 am]
BILLING CODE 4182–02–P
ddrumheller on DSK120RN23PROD with NOTICES1
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. You can also obtain
copies of the proposed collection of
information by emailing infocollection@
acf.hhs.gov. Identify all emailed
requests by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: On September 29, 2023,
FYSB awarded funding for the first time
to Runaway and Homeless YouthPrevention Demonstration Program
(RHY–PDP) projects to design and
deliver community-based demonstration
initiatives to prevent youth from
experiencing homelessness. Through
the development and coordination of
partnerships with youth and young
adults, community organizations, and
private and public agencies, the RHY–
PDP grantees will: (1) design and
develop a comprehensive communitybased prevention plan to prevent youth
homelessness; (2) identify young people
at risk of experiencing homelessness;
and (3) implement robust, holistic
prevention services tailored for youth
and young adults to respond to the
diverse needs of youth who are at risk
Administration for Children and
Families
Office of Community Services,
Administration for Children and
Families, U.S. Department of Health and
Human Services.
AGENCY:
ACTION:
VerDate Sep<11>2014
18:42 Jan 18, 2024
Jkt 262001
PO 00000
Request for public comments.
Frm 00034
Fmt 4703
Sfmt 4703
The Office of Community
Services (OCS), Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS), is requesting to extend
the currently approved Low Income
Home Energy Assistance Program
(LIHEAP) Model Plan Application
(OMB #0970–0075, expiration 12/31/
2023) through August 31, 2024, and
then making significant revisions to the
FY 2025 application to be effective
September 1, 2024. This notice outlines
the proposed revisions for FY 2025.
DATES: Comments due within 30 days of
publication. OMB must make a decision
about the collection of information
between 30 and 60 days after
publication of this document in the
SUMMARY:
E:\FR\FM\19JAN1.SGM
19JAN1
]]>Agencies
[Federal Register Volume 89, Number 13 (Friday, January 19, 2024)]
[Notices]
[Pages 3663-3664]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01014]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2024-0003]
Meeting of the Advisory Committee to the Director, Centers for
Disease Control and Prevention
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting for the Advisory Committee to the Director, Centers
for Disease Control and Prevention (ACD, CDC). This is a hybrid
meeting, accessible both in person and virtually (webcast live via the
World Wide Web). It is open to the public and limited only by the space
available. Time will be available for public comment.
DATES: The meeting will be held on February 21, 2024, from 9 a.m. to 3
p.m., EST (times subject to change).
Written comments must be received on or before February 5, 2024.
ADDRESSES: Meeting address: CDC Roybal Campus, Building 21, Room 1204
A/B, 1600 Clifton Road NE, Atlanta, Georgia 30329-4027.
Please note that the meeting location, the CDC Roybal Campus, is a
federal facility and in-person access is limited to United States
citizens unless prior authorizations, taking up to 30 to 60 days, have
been made. Visitors must follow all directions for access to CDC
facilities. Directions for visitors to CDC, including safety
requirements related to COVID-19; are available at https://www.cdc.gov/screening/visitors.html.
Registration: You must register to attend this meeting in person.
If you wish to attend in person, please submit a request by email to
[email protected] at least 5 business days in advance of the meeting.
No registration is required to view the meeting via the World Wide Web.
Information for accessing the webcast will be available at https://www.cdc.gov/about/advisory-committee-director/.
Written comments: You may submit comments, identified by Docket No.
CDC-2024-0003, by either of the following methods below. Do not submit
comments for the docket by email. CDC does not accept comments for the
docket by email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Kerry Caudwell, DPA, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, Mailstop H21-10, Atlanta, Georgia
30329-4027. Attn: Docket number CDC-2024-0003.
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received will be posted
without change to https://www.regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
Written comments received in advance of the meeting will be included in
the official record of the meeting.
FOR FURTHER INFORMATION CONTACT: Kerry Caudwell, D.P.A., Office of the
Chief of Staff, Centers for Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H21-10, Atlanta, Georgia 30329-4027,
Telephone: (404) 639-0390; Email Address: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee to the Director, CDC, shall (1)
make recommendations to the Director regarding ways to prioritize the
activities of the agency in alignment with the CDC Strategic Plan
required under section 305(c); H.R. 2617-1252; (2) advise on ways to
achieve or improve performance metrics in relation to the CDC Strategic
Plan, and other relevant metrics, as appropriate; (3) provide advice
and recommendations on the development of the Strategic Plan, and any
subsequent updates, as appropriate; (4) advise on grant, cooperative
agreements, contracts, or other transactions, as applicable; (5)
provide other advice to the Director, as requested, to fulfill duties
under sections 301 and 311; and (6) appoint subcommittees. The
committee recommends ways to prioritize CDC's activities, improve
results, and address health disparities. It also provides guidance to
help CDC work more effectively with its various private and public
sector constituents to make health protection a practical reality.
Matters to be Considered: The agenda includes updates on CDC
programs, Director's focus areas, and the Moving Forward Initiative.
Agenda items are subject to change as priorities dictate.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on https://www.regulations.gov.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near duplicate
examples of a mass-mail campaign. CDC will carefully consider all
comments submitted into the docket.
Written Public Comment: The docket will be opened to receive
written comments on January 19, 2024 through February 5, 2024.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
[[Page 3664]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-01014 Filed 1-18-24; 8:45 am]
BILLING CODE 4163-18-P
